000			02009 a2200529 4500
005			20250514014447.0
264		0	_c20011207
008			200112s 0 0 eng d
022			_a0006-4971
024	7		_a10.1182/blood.v98.9.2808 _2doi
040			_aNLM _beng _cNLM
100	1		_aWolff, N C
245	0	0	_aEstablishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571. _h[electronic resource]
260			_bBlood _cNov 2001
300			_a2808-16 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBenzamides
650	0	4	_aBone Marrow Cells _xmetabolism
650	0	4	_aBone Marrow Transplantation
650	0	4	_aDNA-Binding Proteins _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aFusion Proteins, bcr-abl _xgenetics
650	0	4	_aImatinib Mesylate
650	0	4	_aImmediate-Early Proteins _xgenetics
650	0	4	_aLeukemia, Experimental _xdrug therapy
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aLeukocyte Count
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMilk Proteins
650	0	4	_aPiperazines _xadministration & dosage
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aPyrimidines _xadministration & dosage
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRetroviridae _xgenetics
650	0	4	_aSTAT5 Transcription Factor
650	0	4	_aSpleen _xmetabolism
650	0	4	_aSuppressor of Cytokine Signaling Proteins
650	0	4	_aSurvival Rate
650	0	4	_aTrans-Activators _xdrug effects
650	0	4	_aTransduction, Genetic
700	1		_aIlaria, R L
773	0		_tBlood _gvol. 98 _gno. 9 _gp. 2808-16
856	4	0	_uhttps://doi.org/10.1182/blood.v98.9.2808 _zAvailable from publisher's website
999			_c11592524 _d11592524